Hims & Hers Health is a healthcare company that provides telehealth services and wellness products, focusing on personal health and wellness solutions. Its core offerings include prescription medications, over-the-counter products, and health consultations, primarily targeting issues such as sexual health, hair loss, and skincare. The company operates through direct-to-consumer channels, generating revenue from subscription services and product sales.
The investment profile of Hims & Hers Health is more aligned with growth investors, given its focus on expanding its service offerings and market reach. The company currently does not provide dividends and has shown volatility in its earnings. Investors should consider the potential for future growth against the backdrop of higher risk factors.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-08-27 | Hold | Sell | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-08-20 | Sell | Hold | Strong revenue growth, but negative EPS raises concerns. |
| 2026-08-13 | Hold | Sell | Weak fundamentals and high volatility raise concerns. |
| 2026-08-06 | Sell | Hold | Weak fundamentals and high volatility raise concerns. |
| 2026-07-11 | Hold | Sell | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-07-04 | Sell | Hold | Weak fundamentals and high volatility raise concerns. |
| 2026-06-27 | Hold | Sell | Weak fundamentals and high volatility raise concerns. |
| 2026-06-19 | Sell | Hold | Strong momentum but fundamentals show significant weakness. |
| 2026-05-30 | Hold | Sell | Weak fundamentals and high volatility raise significant concerns. |
| 2026-05-14 | Buy | Hold | Weak momentum and high risk; uncertain growth outlook. |
| 2026-05-10 | Hold | Buy | Strong momentum and positive EPS surprise indicate growth potential. |
| 2026-05-08 | — | Hold | Strong EPS surprise, but negative short-term momentum. |
| 2026-05-08 | Hold | Hold | Компания показала значительный рост за последние 20 и 60 дней, однако недавние падения и высокая волатильность указывают на риски. Рекомендуется удерживать акции до более ясных сигналов о стабильности. |
| 2026-03-11 | Sell | Hold | Компания показала значительный рост за последние дни, что может свидетельствовать о восстановлении интереса инвесторов. Однако, учитывая недавние падения, необходимо быть осторожным с возможными колебаниями. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-08-24 | Truist Financial | Target Raised | 27 → 32 | 31.25 |
| 2026-08-20 | Barclays | Target Lowered | — → 35 | 32.83 |
| 2026-08-11 | Deutsche Bank | Target Raised | 25 → 26 | 31.23 |
| 2026-08-11 | Needham | Target Raised | — → 42 | 31.77 |
| 2026-08-11 | Morgan Stanley | Target Raised | 21 → 28 | 31.77 |
| 2026-07-09 | UBS | Target Raised | — → 37 | 36.07 |
| 2026-07-01 | Canaccord Genuity | Target Raised | 32 → 40 | 34.67 |
| 2026-06-17 | Barclays | Target Raised | 29 → 39 | 31.89 |
| 2026-06-02 | Leerink Partners | Update | — → 25 | 27.635 |
| 2026-05-26 | UBS | Target Lowered | — → 25 | 23.75 |
| 2026-05-22 | UBS | Target Raised | 18 → 23 | 23.88 |
| 2026-05-12 | Jefferies | Target Lowered | 25.5 → 24.5 | 25.2801 |
| 2026-05-12 | UBS | Target Raised | 30 → 35 | 25.2248 |
| 2026-05-12 | Canaccord Genuity | Target Raised | 30 → 32 | 29.14 |
| 2026-05-05 | Deutsche Bank | Target Lowered | 28 → 25 | 26.19 |
| 2026-03-10 | Deutsche Bank | Target Raised | 25 → 28 | 23.47 |
| 2026-03-09 | Needham | Update | — → 30 | 22.3501 |
| 2026-03-09 | Oppenheimer | Update | — → 12.5 | 21.58 |
| 2026-02-24 | Barclays | Target Lowered | 48 → 25 | 15.905 |
